Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q4 FY24 results · Jan–Mar 2024
Advanced Enzyme Technologies reported revenue from operations of ₹157.81 crore (up 13.8% from Q4 FY23) and net profit of ₹29.87 crore (down 7.0% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 157.81 | 138.71 | +13.8% | 160.94 | −1.9% |
| Other income | 9.50 | 11.08 | −14.3% | 14.40 | −34.0% |
| Total income | 167.31 | 149.79 | +11.7% | 175.33 | −4.6% |
| Profit before tax | 39.61 | 42.10 | −5.9% | 58.88 | −32.7% |
| Net profit for the period | 29.87 | 32.12 | −7.0% | 42.50 | −29.7% |
| Attributable to shareholders of the company | 28.31 | 32.12 | −11.9% | 41.77 | −32.2% |
| EPS, basic (₹) | 2.53 | 2.87 | −11.8% | 3.74 | −32.4% |
| Net margin (%) | 18.9 | 23.2 | 26.4 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 92.40 | 82.56 | +11.9% | 91.14 | +1.4% |
| Other income | 3.21 | 2.81 | +14.2% | 3.56 | −10.0% |
| Total income | 95.61 | 85.37 | +12.0% | 94.71 | +1.0% |
| Profit before tax | 10.39 | 23.28 | −55.4% | 25.36 | −59.0% |
| Net profit for the period | 3.14 | 17.50 | −82.1% | 19.12 | −83.6% |
| EPS, basic (₹) | 0.28 | 1.56 | −82.1% | 1.71 | −83.6% |
| Net margin (%) | 3.4 | 21.2 | 21.0 |
Consolidated
- Filed with BSE
- 14 May 2024, 12:37 IST
- Board meeting
- 11 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 May 2024, 12:37 IST
- Board meeting
- 11 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE